This week in drug discovery (18-22 October) 

News round-up by DDW’s Megan Thomas for 18-22 October 

DDW’s Megan Thomas has selected five stories which highlight the opportunities in the drug discovery sector.  

1. Researchers receive $4 million for exceptional junior scientists 

Two Mount Sinai cancer researchers will receive $4 million from the National Institutes of Health (NIH) Common Fund, which supports research by junior scientists around the United States. This will fund radiation oncology and CAR T cell cancer therapy research. 

2. CDD launch free software tool 

Collaborative Drug Discovery (CDD) has released a free, full featured, standalone software tool: CDD Visualization. It is a browser-based application that allows scientists to visualise data and generate publication-ready graphs and plots. 

3. Biotech launched to develop treatment for neurodegenerative disease 

A team of medical and pharmaceutical experts has founded SynaptixBio, an Oxford-based research company working to develop the world’s first disease-modifying treatment for TUBB4a leukodystrophy, including H-ABC – a debilitating and potentially life-limiting condition. This is a sponsored research agreement with Children’s Hospital of Philadelphia (CHOP) in the US. 

4. CN Bio service offers support for oncology drug discovery 

CN Bio has launched an oncology service which it says is in response to the global need to improve cancer drug discovery approval rates. 

5. BioIVT enhances its website to facilitate drug and diagnostic R&D 

BioIVT has added advanced tissue, biofluid and cell search and e-commerce capabilities to its website, which is enabling customers to mine its biospecimen repository and related clinical database using artificial intelligence (AI) and machine learning (ML) applications to advance scientific knowledge of different diseases.   

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free